Disc Medicine to Participate in Upcoming Investor Conferences

WATERTOWN, Mass., Aug. 30, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ: IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will participate in fireside chats at four upcoming investor conferences:

• 2024 Wells Fargo Securities Healthcare Conference on Friday, September 6^th at 10:15 a.m. ET.
• Morgan Stanley 22^nd Annual Global Healthcare Conference on Friday, September 6^th at 1:05 p.m. ET.
• H.C. Wainwright 26^th Annual Global Investment Conference on Wednesday, September 11^th at 9:30 a.m. ET.
• 2024 Cantor Global Healthcare Conference on Thursday, September 19^th at 8:00 a.m. ET.

A live webcast of the fireside chats will be available through the investor relations section of the Company's website at ir.discmedicine.com and an archived replay will be available after the event.

About Disc Medicine

Disc Medicine (NASDAQ: IRON) is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases. We are building a portfolio of innovative, potentially first-in-class therapeutic candidates that aim to address a wide spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis. For more information, please visit www.discmedicine.com.

Media Contact

Peg Rusconi
Deerfield Group
[email protected]

Investor Relations Contact

Christina Tartaglia
Precision AQ
[email protected]

You May Also Be Interested In

• Results of the first tranche of AB Tewox bonds
• Ipsen completes acquisition of Kartos Therapeutics, strengthening late-stage Oncology pipeline
• DNO Shares Traded Ex-Dividend